http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2642266-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09b21b85cea35cb05d381736db896ae5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2016-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a0bc0a4dcef09302f3bb063d9c49da3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c375263865db6216aa83d66b18ccdf2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c92af7feb976ac39453f906f15e22c21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de7d3b6e5d698cd470084a5826335be4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24c8c38d421342a23734f8957d197eed |
| publicationDate | 2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2642266-C2 |
| titleOfInvention | Method for ceruloplasmine concentration prediction for trained workers exposed to mercury |
| abstract | FIELD: medicine. n SUBSTANCE: method for prediction of ceruloplasmin concentration in trained workers exposed to mercury includes determination of the ceruloplasmin level and gamma-glutamyltransferase activity in the blood serum, the period of work under mercury exposure is calculated 4-5 years after from the current time, and the results of patient examination are substituted into the equation: Y=-3.77665+3.77665+0.31061×GGT 1 +0.00518×WORKPERD 2 2 +2.01893×CP 1 -0.02850×CP 1 2 where Y is the predicted concentration of ceruloplasmin after 4-5 years, -3.77665 is the constant; 0.31061, 0.00518, 2.01893, 0.02850 are predictor coefficients; GGT 1 is the concentration of gamma-glutamyl transferase in the serum at the time of the examination (U/l), not exceeding 200 U/l; CP 1 is the concentration of ceruloplasmin in the serum for the predicted moment (WORKPERD 2 at the moment of examination +4-5 years). n EFFECT: method allows to judge the risk of cardiovascular diseases development and develop a program for their prevention in a timely manner. n 1 tbl, 3 ex |
| priorityDate | 2016-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.